Drug package insert responsibility

One of the big issues with Reglan / metoclopramide is that the safety warnings got stronger years after it was on the market.

Study looking at how many drug safety issues come up after a medication is on the market demonstrates that we must be  monitoring for safety problems as long as the drug is on the market. For decades even.

Original Investigation
May 9, 2017

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010